Study links gene mutation to miscarriage risk:
This article was originally published in Clinica
A genetic mutation that predisposes women to developing blood clots, has been linked with an increased risk of miscarrying during pregnancy at around 12 weeks, says a team at St Mary's Hospital NHS Trust, In London. Results from a trial show that just 40% of women with a history of recurrent miscarriage and mutation on their Factor V gene, known as Factor V Leiden, had live births, compared with 70% of women with a similar history but with a normal Factor V gene. The findings appear in Human Reproduction (January 30).
You may also be interested in...
According to the plaintiff, Unilever’s Pond’s Rejuveness Anti-Wrinkle Cream is defective insofar as tested product has been found to contain unlabeled mercury, constituting negligence that has resulted in user injuries. The plaintiff seeks certification of a transnational class and compensatory and punitive damages, among other relief.
HBW Product Launches: New Chapter Collagen, Alkamind Acid-Kicking, GNC China, Tetra Bio Canada, More
GNC, Harbin launch supplements in China following regulatory approval; Bee Gone expands with allergy swabs; Bed, Bath & Beyond expands distribution of CBDMedic personal care products promoted by Rob Gronkowski; Tetra Bio has Canadian OK For hemorrhoid and pain relief OTCs, US and European pending; Agrozen offers Urban Daze CBD products; New Chapter portfolio expansion also includes fermented vitamins, elderberry supplements and magnesium; and Alkamind’s Acid-Kicking Coffee Alkalizer creamers help neutralize acid from coffee.
In joint complaint, the FTC and New York Attorney General allege scheme to block generic Daraprim and maintain exorbitant list price; they cite hundreds of emails the incarcerated Shkreli has exchanged with co-defendant in last six months.